November Update on profiled companies - Part two

This time we are looking at IVFH and CPH.TO

Earnings season is almost over. Four of the eight companies featured on this blog have already reported earnings. I covered the first two here.

Today we will cover the next two: Innovation Food Holdings and Cipher Pharmaceuticals. If you are unfamiliar with these names, you can find the original coverage here:

Innovation Food Holdings
Cipher Pharmaceuticals

---

Cipher Pharmaceuticals

After the acquisition of Natroba, Cipher had a great run from CA$10 per share to CA$18. Negative news from Moberg regarding the phase 3 trial in the US initially impacted the share price. Just as it recovered to CA$15, the Q3 results brought it back down to around CA$12. At first, I was surprised that the market reacted so negatively, but after studying the situation a bit more and talking to management, I can better understand the market's reaction. Let me explain: